New York 2023-2024 Regular Session

New York Senate Bill S05439

Introduced
3/6/23  
Refer
3/6/23  

Caption

Designates Xylazine as a schedule III depressant.

Companion Bills

NY A05914

Same As Designates Xylazine as a schedule III depressant.

Previously Filed As

NY S05421

Designates Xylazine as a schedule III depressant.

NY SB1724

Makes xylazine a Schedule III controlled substance

NY SB465

classifying xylazine as a schedule III controlled drug.

NY A10502

Requires polls for special town elections to open on otherwise scheduled general election days, as designated by the state board of elections.

NY S09852

Provides that when a drug is designated or rescheduled by the federal government, it shall be deemed scheduled under NYS law automatically, without further action by the commissioner.

NY HB1881

Adds xylazine to the list of Schedule III controlled substances

NY HB417

Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine

NY HB0417

Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine

NY S07994

Adds home care visits to existing provisions of law prohibiting health care employers from requiring a nurse to work more than such nurse's regularly scheduled work hours, including regularly scheduled home care visits.

NY A08615

Adds home care visits to existing provisions of law prohibiting health care employers from requiring a nurse to work more than such nurse's regularly scheduled work hours, including regularly scheduled home care visits.

Similar Bills

No similar bills found.